Related Experiment Video
Updated: Jun 11, 2026

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
Published on: March 10, 2017
Expression of SDF-1/CXCR4 and related inflammatory factors in sodium fluoride-treated hepatocytes
Rui Yang1,2, Hongting Shen2, Mingjun Wang2
1Department of Public Health, Medical College, Qinghai University, Xi'ning, China.
Abstract:
At present, the mechanism of fluorosis-induced damage to the hepatic system is unclear. Studies have shown that excess fluoride causes some degree of damage to the liver, including inflammation. The SDF-1/CXCR4 signaling axis has been reported to have an impact on the regulation of inflammation in human cells. In this study, we investigated the role of the SDF-1/CXCR4 signaling axis and related inflammatory factors in fluorosis through in vitro experiments on human hepatic astrocytes (LX-2) cultured with sodium fluoride. CCK-8 assays showed that the median lethal dose at 24 h was 2 mmol/l NaF, and these conditions were used for subsequent enzyme-linked immunosorbent assays (ELISAs) and quantitative real-time polymerase chain reaction (qPCR) analysis. The protein expression levels of SDF-1/CXCR4 and the related inflammatory factors nuclear factor-κB (NF-κB), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and interleukin 1β (IL-1β) were detected by ELISAs from the experimental and control groups. The mRNA expression levels of these inflammatory indicators were also determined by qPCR in both groups. Moreover, the expression levels of these factors were significantly higher in the experimental group than in the control group at both the protein and mRNA levels (P < 0.05). Excess fluorine may stimulate the SDF-1/CXCR4 signaling axis, activating the inflammatory NF-κB signaling pathway and increasing the expression levels of the related inflammatory factors IL-6, TNF-α and IL-1β. Identification of this mechanism is important for elucidating the pathogenesis of fluorosis-induced liver injury.
Insights
Excess fluoride exposure triggers liver inflammation by activating the SDF-1/CXCR4 signaling pathway. This pathway increases inflammatory factors like nuclear factor-κB (NF-κB), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interleukin 1β (IL-1β), contributing to liver injury.
Area of Science:
- Hepatology
- Toxicology
- Molecular Biology
Background:
- Fluorosis is linked to liver damage, but the underlying mechanisms remain unclear.
- The SDF-1/CXCR4 signaling axis is implicated in regulating inflammation in human cells.
- Understanding fluoride's impact on liver inflammation is crucial for public health.
Purpose of the Study:
- To investigate the role of the SDF-1/CXCR4 signaling axis in fluorosis-induced liver inflammation.
- To identify key inflammatory factors involved in this process.
- To elucidate the molecular mechanisms of liver injury caused by excess fluoride.
Main Methods:
- In vitro study using human hepatic stellate cells (LX-2) exposed to sodium fluoride (NaF).
- CCK-8 assay to determine the median lethal dose of NaF.
- Enzyme-linked immunosorbent assays (ELISAs) and quantitative real-time polymerase chain reaction (qPCR) to measure protein and mRNA expression levels.
Main Results:
- The median lethal dose of NaF at 24 hours was determined to be 2 mmol/l.
- Protein and mRNA expression of SDF-1/CXCR4, NF-κB, IL-6, TNF-α, and IL-1β were significantly elevated in NaF-treated cells compared to controls (P < 0.05).
- Excess fluoride exposure activates the SDF-1/CXCR4 axis and the NF-κB inflammatory pathway.
Conclusions:
- Excess fluoride stimulates the SDF-1/CXCR4 signaling axis, leading to the activation of the NF-κB pathway.
- This activation results in increased expression of inflammatory factors IL-6, TNF-α, and IL-1β.
- The findings provide insights into the pathogenesis of fluorosis-induced liver injury.
More Related Videos
14:20High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury
Published on: June 16, 2018
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021